|
US4172896A
(en)
|
1978-06-05 |
1979-10-30 |
Dainippon Pharmaceutical Co., Ltd. |
Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
|
|
JPS60243083A
(ja)
|
1984-05-18 |
1985-12-03 |
Nissan Chem Ind Ltd |
ピラゾ−ルスルホニルウレア誘導体、その製法および該誘導体を含有する除草剤
|
|
GB9217295D0
(en)
|
1992-08-14 |
1992-09-30 |
Wellcome Found |
Controlled released tablets
|
|
GB9315856D0
(en)
|
1993-07-30 |
1993-09-15 |
Wellcome Found |
Stabilized pharmaceutical
|
|
US5541231A
(en)
|
1993-07-30 |
1996-07-30 |
Glaxo Wellcome Inc. |
Stabilized Pharmaceutical
|
|
US5358970A
(en)
|
1993-08-12 |
1994-10-25 |
Burroughs Wellcome Co. |
Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
|
|
US5569655A
(en)
|
1993-09-14 |
1996-10-29 |
Sterling Winthrop Inc. |
Substituted heterocyclylisoquinolinium salts and compositions and method of use thereof
|
|
TW401301B
(en)
|
1994-10-07 |
2000-08-11 |
Takeda Chemical Industries Ltd |
Antihypertriglyceridemic composition
|
|
AR002459A1
(es)
|
1995-01-17 |
1998-03-25 |
American Cyanamid Co |
Antagonistas de vasopresina de benzacepina triciclicos, una composicion farmaceutica que los contiene, un metodo para tratar enfermedades y unprocedimiento para su preparacion.
|
|
US5849735A
(en)
|
1995-01-17 |
1998-12-15 |
American Cyanamid Company |
Tricyclic benzazepine vasopressin antagonists
|
|
ATE391492T1
(de)
|
1997-07-29 |
2008-04-15 |
Alcon Lab Inc |
Ophthalmische zusammensetzungen enthaltend galaktomannanpolymere und borat
|
|
WO1999038504A1
(en)
|
1998-01-29 |
1999-08-05 |
Sepracor Inc. |
Pharmaceutical uses of optically pure (-)-bupropion
|
|
US8889112B2
(en)
|
1999-09-16 |
2014-11-18 |
Ocularis Pharma, Llc |
Ophthalmic formulations including selective alpha 1 antagonists
|
|
ES2269302T3
(es)
|
2000-12-20 |
2007-04-01 |
Kyowa Hakko Chemical Co., Ltd. |
Compuestos de escuarilio tipo complejos metalicos y medios de grabacion opticos que usan los mismos.
|
|
DE10239042A1
(de)
*
|
2002-08-21 |
2004-03-04 |
Schering Ag |
Makrozyclische Pyrimidine, deren Herstellung und Verwendung als Arzneimittel
|
|
AU2003268752A1
(en)
|
2002-10-30 |
2004-05-25 |
Sumitomo Chemical Company, Limited |
High-molecular compounds and polymerer light emitting devices made by using the same
|
|
US6933289B2
(en)
|
2003-07-01 |
2005-08-23 |
Allergan, Inc. |
Inhibition of irritating side effects associated with use of a topical ophthalmic medication
|
|
DE602004023516D1
(de)
|
2003-08-07 |
2009-11-19 |
Allergan Inc |
Zusammensetzungen zur abgabe von therapeutika in die augen und verfahren zu ihrer herstellung und verwendung
|
|
US20050059744A1
(en)
|
2003-09-12 |
2005-03-17 |
Allergan, Inc. |
Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
|
|
AR049631A1
(es)
|
2004-04-27 |
2006-08-23 |
Wyeth Corp |
Proceso de acoplamiento para la generacion de derivados reactivos de pirrol -2- carbonitrilo n- sustituidos con contenido de boro para producir biarilos
|
|
CA2563063C
(en)
|
2004-04-27 |
2014-06-03 |
Wyeth |
Purification of progesterone receptor modulators
|
|
DOP2005000123A
(es)
|
2004-07-02 |
2011-07-15 |
Merck Sharp & Dohme |
Inhibidores de cetp
|
|
JP5031570B2
(ja)
|
2004-09-20 |
2012-09-19 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
性ステロイドホルモン受容体モジュレーターとして有用な新規な四環式ヘテロ原子含有誘導体
|
|
US7445211B1
(en)
|
2005-03-11 |
2008-11-04 |
Walton Daniel J |
Wall decoration and game apparatus
|
|
US20070116984A1
(en)
|
2005-09-21 |
2007-05-24 |
Doosan Corporation |
Spiro-compound for electroluminescent display device and electroluminescent display device comprising the same
|
|
US20090022694A1
(en)
|
2005-10-18 |
2009-01-22 |
Distefano Peter |
Sirt1 inhibition
|
|
GB0526044D0
(en)
|
2005-12-21 |
2006-02-01 |
Syngenta Ltd |
Novel herbicides
|
|
NZ570257A
(en)
|
2006-02-16 |
2011-11-25 |
Anacor Pharmaceuticals Inc |
Boron-containing small molecules as anti-inflammatory agents
|
|
GB0603891D0
(en)
|
2006-02-27 |
2006-04-05 |
Syngenta Ltd |
Novel herbicides
|
|
US20070213526A1
(en)
|
2006-03-07 |
2007-09-13 |
Wyeth |
Purification of progesterone receptor modulators
|
|
GB0609492D0
(en)
|
2006-05-15 |
2006-06-21 |
Angeletti P Ist Richerche Bio |
Therapeutic agents
|
|
US7915414B2
(en)
|
2006-11-24 |
2011-03-29 |
Yun Chi |
Blue-emitting organometallic complexes and their application
|
|
FR2913882B1
(fr)
|
2007-03-20 |
2009-05-01 |
Oreal |
Utilisation pour la coloration des fibres keratiniques d'une composition comprenant un compose halochromique et/ou le colorant correspondant a ce compose
|
|
AU2008267443A1
(en)
|
2007-06-26 |
2008-12-31 |
Sanofi-Aventis |
A regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles
|
|
CN101784553A
(zh)
|
2007-07-02 |
2010-07-21 |
阿斯利康(瑞典)有限公司 |
3-螺嘧啶三酮-喹啉衍生物及其作为抗菌药物的应用
|
|
US9446995B2
(en)
|
2012-05-21 |
2016-09-20 |
Illinois Institute Of Technology |
Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
|
|
US10189803B2
(en)
|
2008-02-22 |
2019-01-29 |
Illinois Institute Of Technology |
Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
|
|
BRPI0908565A2
(pt)
|
2008-03-06 |
2017-05-23 |
Anacor Pharmaceuticals Inc |
composto, formulação farmacêutica, métodos para reduzir a liberação de uma citocina ou de uma quimiocina, para tratar uma condição em um animal e para inibir uma fosfodiesterase
|
|
JP2009234928A
(ja)
|
2008-03-25 |
2009-10-15 |
Kyoto Univ |
縮合多環芳香族化合物、およびその製造方法
|
|
JP5304010B2
(ja)
|
2008-04-23 |
2013-10-02 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子、表示装置及び照明装置
|
|
JP5499519B2
(ja)
|
2009-05-27 |
2014-05-21 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子、表示装置及び照明装置
|
|
PT2463280E
(pt)
|
2009-08-04 |
2013-11-11 |
Tokuyama Corp |
Composto de cromeno
|
|
JP4599469B1
(ja)
|
2009-08-31 |
2010-12-15 |
富士フイルム株式会社 |
有機電界発光素子用材料及び有機電界発光素子
|
|
US8410091B1
(en)
|
2009-09-11 |
2013-04-02 |
Boehringer Ingelheim International Gmbh |
Process for preparation of substituted 2-amino-5-(5-(heterocyclemethyl)pyridin-2-yloxy)benzoic acid
|
|
SG179163A1
(en)
|
2009-09-16 |
2012-05-30 |
Cylene Pharmaceuticals Inc |
Novel tricyclic protein kinase modulators
|
|
US8916593B2
(en)
|
2010-05-04 |
2014-12-23 |
Pfizer Inc. |
Alkoxy-substituted 2-aminopyridines as ALK inhibitors
|
|
EP2598510A4
(en)
|
2010-07-30 |
2014-02-26 |
Reddys Lab Ltd Dr |
LIGANDS FOR SELECTIVE ASYMMETRIC HYDROFORMYLATION
|
|
US20120157448A1
(en)
|
2010-11-22 |
2012-06-21 |
Adam Cook |
Compounds for treating neurodegenerative diseases
|
|
ES2524423T3
(es)
|
2010-12-01 |
2014-12-09 |
Pfizer Inc. |
Inhibidores de KAT II
|
|
ES2559519T3
(es)
|
2010-12-22 |
2016-02-12 |
Université Catholique de Louvain |
Nuevos derivados de fenazina y su uso
|
|
FR2969611B1
(fr)
|
2010-12-28 |
2013-02-08 |
Sanofi Aventis |
Nouveaux derives de thiazoles, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de phosphorylation d'akt(pkb)
|
|
LT2658844T
(lt)
|
2010-12-28 |
2017-02-10 |
Sanofi |
Nauji pirimidino dariniai, jų gamyba ir jų farmacinis panaudojimas kaip akt (pkb) fosforilinimo slopiklių
|
|
ES2543757T3
(es)
|
2011-01-27 |
2015-08-21 |
Tokuyama Corporation |
Compuesto de cromeno
|
|
WO2012138648A1
(en)
|
2011-04-06 |
2012-10-11 |
Irm Llc |
Compositions and methods for modulating lpa receptors
|
|
EP2705039B1
(en)
|
2011-05-04 |
2017-07-26 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
CN102408385B
(zh)
|
2011-06-20 |
2014-06-18 |
雅本化学股份有限公司 |
一种2-取代-2h-1,2,3-三氮唑衍生物的制备方法
|
|
TW201311689A
(zh)
|
2011-08-05 |
2013-03-16 |
必治妥美雅史谷比公司 |
作為因子ｘｉａ抑制劑之新穎巨環化合物
|
|
TWI506030B
(zh)
|
2011-09-06 |
2015-11-01 |
Nat Univ Tsing Hua |
含有碳烯配位基的過渡金屬錯合物結構及其在發光材料的應用
|
|
JPWO2013125543A1
(ja)
|
2012-02-20 |
2015-07-30 |
武田薬品工業株式会社 |
複素環化合物
|
|
CN102603659B
(zh)
|
2012-03-01 |
2014-03-26 |
雅本化学股份有限公司 |
1-取代-4-溴-1h-1,2,3-三氮唑-5-羧酸及其制备方法
|
|
WO2013132376A1
(en)
*
|
2012-03-06 |
2013-09-12 |
Pfizer Inc. |
Macrocyclic derivatives for the treatment of proliferative diseases
|
|
KR20140032823A
(ko)
|
2012-09-07 |
2014-03-17 |
롬엔드하스전자재료코리아유한회사 |
유기 전계 발광 소자
|
|
US9502667B2
(en)
|
2013-01-24 |
2016-11-22 |
Idemitsu Kosan Co., Ltd. |
Organic electroluminescence
|
|
WO2014138912A1
(en)
|
2013-03-13 |
2014-09-18 |
Queen's University At Kingston |
Luminescent compounds and methods of using same
|
|
EP3013835B1
(en)
|
2013-06-28 |
2017-12-13 |
Pfizer Inc |
Solid forms of a macrocyclic kinase inhibitor
|
|
WO2015025197A1
(en)
|
2013-08-22 |
2015-02-26 |
Jubilant Biosys Limited |
Substituted pyrimidine compounds, compositions and medicinal applications thereof
|
|
KR102100929B1
(ko)
|
2013-09-04 |
2020-04-14 |
삼성전자주식회사 |
축합환 화합물 및 이를 포함한 유기 발광 소자
|
|
CN104513253A
(zh)
*
|
2013-10-01 |
2015-04-15 |
南京波尔泰药业科技有限公司 |
用于治疗增殖性疾病的大环化合物
|
|
US20160256448A1
(en)
|
2013-11-18 |
2016-09-08 |
Forma Therapeutics, Inc. |
Tetrahydroquinoline compositions as bet bromodomain inhibitors
|
|
PT3071203T
(pt)
|
2013-11-18 |
2021-03-11 |
Forma Therapeutics Inc |
Composições de tetra-hidroquinolina como inibidores de bromodomínio bet
|
|
KR102167048B1
(ko)
|
2013-12-03 |
2020-10-19 |
삼성디스플레이 주식회사 |
화합물 및 이를 포함한 유기 발광 소자
|
|
ES2902835T3
(es)
|
2014-01-09 |
2022-03-30 |
Hadasit Med Res Service |
Composiciones celulares mejoradas y métodos para la terapia contra el cáncer
|
|
KR102191992B1
(ko)
|
2014-01-22 |
2020-12-17 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
|
KR102253441B1
(ko)
|
2014-03-10 |
2021-05-20 |
삼성디스플레이 주식회사 |
화합물 및 이를 포함한 유기 발광 소자
|
|
CN105130966B
(zh)
|
2014-05-07 |
2019-05-24 |
广东东阳光药业有限公司 |
炔基化合物及其使用方法和用途
|
|
WO2015175579A1
(en)
|
2014-05-15 |
2015-11-19 |
Calitor Sciences, Llc |
Alkynyl compounds and methods of use
|
|
WO2016026423A1
(en)
*
|
2014-08-20 |
2016-02-25 |
Teligene Ltd |
Substituted macrocycles useful as kinases inhibitors and methods of use thereof
|
|
KR101793335B1
(ko)
|
2014-09-30 |
2017-11-02 |
주식회사 엘지화학 |
헤테로고리 화합물 및 이를 포함하는 유기 발광 소자
|
|
CN105585534B
(zh)
|
2014-10-23 |
2018-05-18 |
上海雅本化学有限公司 |
一种1-取代-1h-1,2,3-三氮唑-4-羧酸的制备方法
|
|
US20160140491A1
(en)
|
2014-11-17 |
2016-05-19 |
Gregory Forgatch |
System and method for integrating intermediary and end-user online retail experiences
|
|
PH12021553074A1
(en)
|
2015-01-22 |
2023-03-06 |
Myokardia Inc |
4-methylsulfonyl-substituted piperidine urea compounds for the treatment of dilated cardiomyopathy (dcm)
|
|
US9887372B2
(en)
|
2015-06-11 |
2018-02-06 |
Samsung Display Co., Ltd. |
Amine-based compound and organic light-emitting device including the same
|
|
EP3331889B1
(en)
|
2015-08-03 |
2020-09-23 |
Bristol-Myers Squibb Company |
Cyclic compounds useful as modulators of tnf alpha
|
|
WO2017080980A1
(en)
|
2015-11-09 |
2017-05-18 |
Astrazeneca Ab |
Dihydropyrrolopyrazinone derivatives useful in the treatment of cancer
|
|
KR20180097542A
(ko)
|
2015-11-13 |
2018-08-31 |
마발론 테라퓨틱스 리미티드 |
그룹 ii 대사성 글루타메이트 수용체의 알로스테릭 조절제로서의 치환된 트리사이클릭 1,4-벤조디아제피논 유도체
|
|
KR20180082557A
(ko)
|
2015-11-25 |
2018-07-18 |
길리어드 아폴로, 엘엘씨 |
트리아졸 acc 억제제 및 그의 용도
|
|
CN105669733A
(zh)
|
2016-01-29 |
2016-06-15 |
上海毕路得医药科技有限公司 |
一种1-甲基-1h-吡唑-3-硼酸频哪醇酯的合成方法
|
|
WO2017148325A1
(zh)
|
2016-03-03 |
2017-09-08 |
深圳市塔吉瑞生物医药有限公司 |
一种大环化合物及包含该化合物的组合物
|
|
CN106243096B
(zh)
|
2016-07-29 |
2019-11-29 |
上海璃道医药科技有限公司 |
三环类药物的新用途
|
|
JP6798851B2
(ja)
|
2016-10-14 |
2020-12-09 |
株式会社トクヤマ |
クロメン化合物、及び該クロメン化合物を含む硬化性組成物
|
|
WO2018111803A1
(en)
|
2016-12-13 |
2018-06-21 |
Boehringer Ingelheim International Gmbh |
Compounds as modulators of ror gamma
|
|
CN109528717B
(zh)
|
2017-09-21 |
2021-08-17 |
中国科学院分子细胞科学卓越创新中心 |
治疗或预防肥胖或其相关疾病的化合物及其应用
|
|
JOP20180092A1
(ar)
|
2017-10-13 |
2019-04-13 |
Gilead Sciences Inc |
مثبطات hiv بروتياز
|
|
WO2019113071A1
(en)
|
2017-12-05 |
2019-06-13 |
Icahn School Of Medicine At Mount Sinai |
Compositions and methods for treating alk-mediated cancer
|
|
WO2019120263A1
(zh)
|
2017-12-21 |
2019-06-27 |
广州华睿光电材料有限公司 |
有机混合物及其在有机电子器件中的应用
|
|
CN111511749B
(zh)
*
|
2018-01-30 |
2022-02-08 |
上海吉倍生物技术有限公司 |
具有大环分子结构的化合物及其用途
|
|
EP3750909B1
(en)
|
2018-02-11 |
2025-03-05 |
Jiangsu Hansoh Pharmaceutical Group Co., Ltd. |
Steroid derivative regulators, method for preparing the same, and uses thereof
|
|
WO2019164301A1
(ko)
|
2018-02-21 |
2019-08-29 |
주식회사 엘지화학 |
화합물 및 이를 포함하는 유기 발광 소자
|
|
KR102192368B1
(ko)
|
2018-02-28 |
2020-12-17 |
주식회사 엘지화학 |
유기 발광 소자
|
|
CN110357905B
(zh)
|
2018-03-26 |
2021-10-01 |
武汉誉祥医药科技有限公司 |
作为蛋白激酶抑制剂的大环类衍生物及其制备方法和用途
|
|
CN108912175A
(zh)
|
2018-06-05 |
2018-11-30 |
长春海谱润斯科技有限公司 |
一种金属铱配合物及其有机发光器件
|
|
CN112771035A
(zh)
|
2018-07-26 |
2021-05-07 |
恩特姆生物科学公司 |
用于制备甘露糖衍生物的方法
|
|
US10593889B1
(en)
|
2018-09-26 |
2020-03-17 |
Idemitsu Kosan Co., Ltd. |
Compound and organic electroluminescence device
|
|
EP3856192B1
(en)
|
2018-09-27 |
2024-09-11 |
Dana-Farber Cancer Institute, Inc. |
Degraders that target alk and therapeutic uses thereof
|
|
CA3118094A1
(en)
|
2018-10-30 |
2020-05-07 |
Bristol-Myers Squibb Company |
Amide-substituted heterocyclic compounds for the treatment of conditions related to the modulation of il-12, il-23 and/or ifn-alpha
|
|
CN109912433B
(zh)
|
2019-03-07 |
2022-04-08 |
石家庄诚志永华显示材料有限公司 |
化合物、有机电致发光材料、有机电致发光器件、电子装置
|
|
KR20200111577A
(ko)
|
2019-03-19 |
2020-09-29 |
삼성전자주식회사 |
축합환 화합물 및 이를 포함한 유기 발광 소자
|
|
JP7345901B2
(ja)
|
2019-05-14 |
2023-09-19 |
テリジーン リミテッド |
キナーゼ阻害剤として有用な置換大員環類
|
|
US20220298130A1
(en)
|
2019-08-02 |
2022-09-22 |
Duk San Neolux Co., Ltd. |
Organic electronic device
|
|
CN112321604A
(zh)
|
2019-08-05 |
2021-02-05 |
华东理工大学 |
大环类jak2抑制剂及其应用
|
|
GB201913756D0
(en)
|
2019-09-24 |
2019-11-06 |
Chromatwist Ltd |
Contrast agent
|
|
US20220402948A1
(en)
|
2019-09-26 |
2022-12-22 |
Betta Pharmaceuticals Co., Ltd. |
Egfr inhibitor, composition and preparation method therefor
|
|
US20230027026A1
(en)
|
2019-09-27 |
2023-01-26 |
Jubilant Biosys Limited |
Fused pyrimidine compounds, compositions and medicinal applications thereof
|
|
CN110734456A
(zh)
|
2019-11-06 |
2020-01-31 |
南京谷睿生物科技有限公司 |
一种化合物及其制备方法和医药上的应用
|
|
AU2020384883B2
(en)
|
2019-11-15 |
2023-11-16 |
Gilead Sciences, Inc. |
Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereof
|
|
CN112812128B
(zh)
|
2019-11-18 |
2024-04-02 |
正大天晴药业集团股份有限公司 |
作为alk和ros调节剂的大环化合物
|
|
JP7398566B2
(ja)
|
2019-12-16 |
2023-12-14 |
アイセンス，インコーポレーテッド |
遷移金属錯体、電子伝達媒介体として使用される化合物、遷移金属錯体の製造方法、遷移金属錯体を電子伝達媒介体として含む装置、電気化学的バイオセンサ用センシング膜
|
|
TW202136246A
(zh)
|
2019-12-19 |
2021-10-01 |
德商麥克專利有限公司 |
電子裝置用化合物
|
|
CN113121607B
(zh)
|
2019-12-31 |
2023-07-04 |
马鞍山南大高新技术研究院有限公司 |
一种主配体含喹啉/喹唑啉的红光铱配合物与应用
|
|
WO2021197276A1
(en)
|
2020-03-30 |
2021-10-07 |
Hutchison Medipharma Limited |
Amide compounds and uses thereof
|
|
CN111440154B
(zh)
|
2020-04-24 |
2022-04-19 |
梯尔希（南京）药物研发有限公司 |
一种替格列汀二聚体杂质的合成方法
|
|
CN111362967B
(zh)
|
2020-04-28 |
2021-09-07 |
南京雷正医药科技有限公司 |
苯并氧杂二氮杂十四碳烯衍生物及其用途
|
|
KR102698413B1
(ko)
|
2020-05-05 |
2024-08-26 |
뉴베일런트, 아이엔씨. |
헤테로방향족 거대환식 에터 화학치료제
|
|
KR20240132391A
(ko)
|
2020-05-05 |
2024-09-03 |
뉴베일런트, 아이엔씨. |
헤테로방향족 거대환식 에터 화학치료제
|
|
US12545689B2
(en)
|
2020-05-06 |
2026-02-10 |
Oncodesign Precision Medicine |
Macrocyclic LRRK2 kinase inhibitors
|
|
US20230174554A1
(en)
|
2020-05-18 |
2023-06-08 |
Shenzhen TargetRx. Inc. |
Solid form of macrocyclic compound, preparation therefor and use thereof
|
|
TWI838626B
(zh)
|
2020-06-03 |
2024-04-11 |
美商基利科學股份有限公司 |
Lpa受體拮抗劑及其用途
|
|
JP7591066B2
(ja)
|
2020-06-03 |
2024-11-27 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｌｐａ受容体アンタゴニスト及びそれらの使用
|
|
WO2022194399A1
(en)
|
2020-07-13 |
2022-09-22 |
Idorsia Pharmaceuticals Ltd |
Macrocycles as cftr modulators
|
|
WO2022017408A1
(zh)
|
2020-07-22 |
2022-01-27 |
中国医药研究开发中心有限公司 |
芳胺类衍生物及其制备方法和医药用途
|
|
CN111808147B
(zh)
|
2020-07-28 |
2023-04-18 |
奥来德(上海)光电材料科技有限公司 |
一种有机磷光材料及其制备方法和电致发光器件
|
|
CA3207819A1
(en)
|
2021-02-19 |
2022-08-25 |
Anjali Pandey |
Tyk2 inhibitors and uses thereof
|
|
WO2022198196A1
(en)
|
2021-03-15 |
2022-09-22 |
Maze Therapeutics, Inc. |
Inhibitors of glycogen synthase 1 (gys1) and methods of use thereof
|
|
WO2022212538A1
(en)
|
2021-03-31 |
2022-10-06 |
Blueprint Medicines Corporation |
Diazepanone-fused pyrimidine compounds, compositions and medicinal applications thereof
|
|
CN113105440B
(zh)
|
2021-04-15 |
2022-10-04 |
吉林奥来德光电材料股份有限公司 |
一种有机电致发光化合物及其制备方法和应用
|
|
KR20240007233A
(ko)
|
2021-05-13 |
2024-01-16 |
길리애드 사이언시즈, 인코포레이티드 |
Lpa 수용체 길항제 및 이의 용도
|
|
EP4337655A1
(en)
|
2021-05-14 |
2024-03-20 |
Bristol-Myers Squibb Company |
Substituted heterocyclic compounds
|
|
IL311444A
(en)
|
2021-10-01 |
2024-05-01 |
Nuvalent Inc |
Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compounds
|
|
CA3231608A1
(en)
|
2021-10-01 |
2023-04-06 |
Amit M. Deshpande |
Methods of treating solid tumor using heteroaromatic macrocyclic ether compounds
|
|
WO2023059801A1
(en)
|
2021-10-06 |
2023-04-13 |
The Regents Of The University Of Colorado, A Body Corporate |
Biomarkers for egfr-mediated resistance in oncogene-driven cancers and methods of treating, preventing, and/or ameliorating oncogene-driven cancers
|
|
WO2023179600A1
(zh)
|
2022-03-21 |
2023-09-28 |
杭州德睿智药科技有限公司 |
新型取代大杂环类新化合物及其应用
|
|
AU2023249641A1
(en)
|
2022-04-07 |
2024-09-26 |
Nuvalent, Inc. |
Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compounds
|